This company listing is no longer active
Scandinavian ChemoTech Balance Sheet Health
Financial Health criteria checks 6/6
Scandinavian ChemoTech has a total shareholder equity of SEK7.9M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK16.2M and SEK8.3M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 1.66m |
| Equity | SEK 7.89m |
| Total liabilities | SEK 8.32m |
| Total assets | SEK 16.21m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CMOTEC BTA B's short term assets (SEK9.0M) exceed its short term liabilities (SEK8.3M).
Long Term Liabilities: CMOTEC BTA B has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: CMOTEC BTA B is debt free.
Reducing Debt: CMOTEC BTA B has no debt compared to 5 years ago when its debt to equity ratio was 2.2%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CMOTEC BTA B has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: CMOTEC BTA B is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.